(Q67485508)
Statements
A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer (English)
1 reference
1 reference
M. Fukuoka
H. Niitani
A. Suzuki
M. Motomiya
K. Hasegawa
Y. Nishiwaki
T. Kuriyama
Y. Ariyoshi
S. Negoro
1 January 1992